Literature DB >> 14697261

Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions.

Takeshi Sakata1, Naohiko Anzai, Ho Jung Shin, Rie Noshiro, Taku Hirata, Hirokazu Yokoyama, Yoshikatsu Kanai, Hitoshi Endou.   

Abstract

Organic cation transporter OCT1 (SLC22A1) plays an essential role in absorption, distribution, and excretion of various xenobiotics including therapeutically important drugs. In the present study, we analyzed the functional properties of the single nucleotide polymorphisms (SNPs) in SLC22A1 gene found in Japanese control individuals. Four mutations resulting in the amino acid changes (F160L, P283L, R287G, and P341L) were functionally characterized in Xenopus oocyte expression system. Two new SNPs, identified in Japanese population, P283L and R287G exhibited no uptake of both [14C]TEA and [3H]MPP+, although their protein expressions were detected in the plasma membrane of the oocytes injected with their cRNAs. Uptake of [14C]TEA by P341L was reduced to 65.1% compared to wild type, whereas F160L showed no significant change in its transport activity. This study suggests that the newly found OCT1 variants will contribute to inter-individual variations leading to the differences in cationic drug disposition and perhaps certain disease processes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14697261     DOI: 10.1016/j.bbrc.2003.11.175

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  The pharmacogenetics of metformin.

Authors:  Jose C Florez
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

2.  Genetic polymorphisms of the organic cation transporter 1 gene (SLC22A1) within the Cape Admixed population of South Africa.

Authors:  Morne Du Plessis; Brendon Pearce; Clifford Jacobs; Nisreen Hoosain; Mongi Benjeddou
Journal:  Mol Biol Rep       Date:  2014-11-15       Impact factor: 2.316

Review 3.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 4.  OCT1 and imatinib transport in CML: is it clinically relevant?

Authors:  D B Watkins; T P Hughes; D L White
Journal:  Leukemia       Date:  2015-07-09       Impact factor: 11.528

Review 5.  Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.

Authors:  Gaia Chiara Mannino; Giorgio Sesti
Journal:  Mol Diagn Ther       Date:  2012-10       Impact factor: 4.074

6.  Association of SLCO1B3 polymorphism with intracellular accumulation of imatinib in leukocytes in patients with chronic myeloid leukemia.

Authors:  Takeru Nambu; Akinobu Hamada; Reiko Nakashima; Misato Yuki; Tatsuya Kawaguchi; Hiroaki Mitsuya; Hideyuki Saito
Journal:  Biol Pharm Bull       Date:  2011       Impact factor: 2.233

7.  Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.

Authors:  Yan Shu; Steven A Sheardown; Chaline Brown; Ryan P Owen; Shuzhong Zhang; Richard A Castro; Alexandra G Ianculescu; Lin Yue; Joan C Lo; Esteban G Burchard; Claire M Brett; Kathleen M Giacomini
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  Genetic polymorphisms of OCT-1 confer susceptibility to severe progression of primary biliary cirrhosis in Japanese patients.

Authors:  Yuki Ohishi; Makoto Nakamuta; Naoko Ishikawa; Ohki Saitoh; Hitomi Nakamura; Yoshihiro Aiba; Atsumasa Komori; Kiyoshi Migita; Hiroshi Yatsuhashi; Nobuyoshi Fukushima; Motoyuki Kohjima; Tsuyoshi Yoshimoto; Kunitaka Fukuizumi; Makoto Ishibashi; Takashi Nishino; Ken Shirabe; Akinobu Taketomi; Yoshihiko Maehara; Hiromi Ishibashi; Minoru Nakamura
Journal:  J Gastroenterol       Date:  2013-04-24       Impact factor: 7.527

Review 9.  An update on the pharmacogenomics of metformin: progress, problems and potential.

Authors:  Jennifer N Todd; Jose C Florez
Journal:  Pharmacogenomics       Date:  2014-03       Impact factor: 2.533

Review 10.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.